Giridharan Periyasamy

Title: **Innovative Contributions of Giridharan Periyasamy in Melanoma Treatment**

Introduction

Giridharan Periyasamy, based in Mumbai, India, is a notable inventor with a remarkable portfolio comprising four patents. His innovative work primarily focuses on advancements in pharmaceuticals, particularly concerning the treatment of melanoma, a serious form of skin cancer.

Latest Patents

Among his latest inventions, Giridharan has developed a pharmaceutical combination for the treatment of melanoma. This innovative formulation includes a cyclin-dependent kinase (CDK) inhibitor, represented by a specific compound, or its pharmaceutically acceptable salt. The invention also integrates at least one anticancer agent selected from BRAF or MEK inhibitors aimed at enhancing the efficacy of melanoma treatment. The methodology entails administering a therapeutically effective amount of both a CDK inhibitor and at least one anticancer agent, providing a significant advancement in patient care for those suffering from this aggressive cancer.

Career Highlights

Giridharan works at Piramal Enterprises Limited, a leading player in the pharmaceutical sector. His work contributes significantly to the organization's efforts in cancer research and drug development, marking him as an influential figure in the field.

Collaborations

Throughout his career, Giridharan has collaborated with esteemed colleagues such as Veena R Agarwal and Maggie Rathos. These partnerships illustrate the importance of teamwork in fostering innovation and advancing pharmaceutical research.

Conclusion

Giridharan Periyasamy stands out as a dedicated inventor, making substantial contributions to melanoma treatment through his innovative patents. His work not only showcases his expertise but also highlights the collaborative spirit within the pharmaceutical industry that drives progress in medical advancements.